Work

Supplementary Figure S2 from ESR1 Y537S and D538G Mutations Drive Resistance to CDK4/6 Inhibitors in Estrogen Receptor–Positive Breast Cancer

Year: 2026

Type: supplementary-materials

Abstract: ESR1 Y537S and D538G alterations promote resistance to ribociclib ± estrogen deprivation in vitro

DOI: 10.1158/1078-0432.32712466

Authors: Chang-Ching A. Lin, María Rosario Chica-Parrado, Nisha Unni, Ellen Jaeger, Yisheng V. Fang, Lei Guo, Fabiana Napolitano, Pamela Luna, Michelle Harris, Calvin Chao, Lin Xu, Carlos L. Arteaga, Ariella B. Hanker

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7164986149

Cites:

Cited by:

Related to: 10